Minsoo Park 2nd Vice Minister of Health and Welfare

Key note Speech ① : Digital healthcare and medical innovation

- Secretary to the President for Health and Welfare Office of the President
- Deputy Minister for Planning and Coordination Ministry of Health and Welfare
- Director General for Welfare Policy Ministry of Health and Welfare
- Director General for Policy Planning Ministry of Health and Welfare
- Minister-Counsellor Embassy of the Republic of Korea to the United States of America
- Senior Administrative Officer for Health and Welfare Office of the President of the Republic of Korea

Sasha Semienchuk VP & General Manager– Novo Nordisk Korea

Key note Speech ② : Convergence of medicines and digital health to treat chronic diseases

- Novo Nordisk Pharma Korea, General Manager
- MBA from ESADE Business School, Spain
- Masters degree in Biomedical Engineering from McGill University, Canada
- Over 20 years of career in healthcare sector
- Extensive experiences at Novo Nordisk, including the initial commercial launch into obesity and establishing multiple digital health partnerships

Kyung Dae Seong Digital Pharm COO (Chief Operating Officer)

BIO Trend ① : The industrial prospect and role of digital healthcare from the perspective of pharmaceutical companies

- General Director of Strategic Marketing Team, Hanmi Pharmaceutical
- Research Director of Big Data Clinical Utilization Research Group
- Vice Chairman of the Digital Health Committee of the KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
- Planning and Developing Director of the Korean Society of Health Information and Statistics
- Industry-Academic Advisory Committee Member of the Korean Society of Digital Clinical Medicine
- Industrial Committee Member of the Artificial Intelligence Data Research Group of the Korean Heart Failure Association

Taeeon Koo LIN P.C., TMT Group Lead Attorney

BIO Trend ② : Regulatory limitations related to AI customized medical digital services

- LIN P.C., TMT Group Lead Attorney
- Digital Platform Government Committee, Commissioner & My Data TF Leader
- Digital Healthcare Industry Association, Regulatory Committee Chair
- Korea University School of Cybersecurity, Mater Degree

Chair & Participants) Hyunsang Muk CEO, Korea Drug Development Fund

Discussion

- CEO, Korea Drug Development Fund
- Head of the business division, Korea Drug Development Fund
- Member of the Investment Deliberation Committee, Korea Drug Development Fund
- Director, Korea Bio(Korea Biotechnology Industry Organization)
- CEO, Medifron
- BS, MS in Industrial Engineering, Seoul National University

Jongho Heo Director, Quality of Life Data Center, National Assembly Futures Institute

Discussion

- Director, Quality of Life Data Center, National Assembly Futures Institute
- Adjunct Associate Professor, Department of Human Systems Medicine, Seoul National University College of Medicine
- Ph.D., UC San Diego (Public Health)
- Assistant Legislative Researcher, National Assembly Research Services
- M.P.H., Seoul National University Graduate School of Public Health

Jade Kim CEO, Inventage Lab

IR Session

- Chief, Clinical development team, BCWorld Pharm
- Manager, Academic team, Seegene
- R&D Center, Kwangdong Pharmaceutical
- Ph.D in Biocemistry, Kyungpook National University
- Masters in Biochemestry, Hanyang University Medical School

Sanggoo Kang CEO, Medy Sapiens, Inc.

IR Session

- Medy Sapiens, Inc. (Healthcare Data Sciences) CEO, 2017~present
- DNA Link (Genomics Service Provider in Seoul, Korea, KOSDAQ) COO/VP. 2014-2017
- 3M (St. Paul, Minnesota) Marketing Director, Screen Protectors, 2010-2013: Healthcare (skin care and dermatology)
- Toshiba America (Irvine, California) Notebook Marketing Director, 2007-2009: Xray / CT / MRI medical devices
- Samsung Electronics America (Irvine, California) VSS Business Manager, 2004-2007
- Nortel Networks (RTP, North Carolina) Northeast CLECs Business Development Manager, 1999-2002
- J.P. Morgan (NYC, New York) Investment Banking Associate,1988

SEAN G. KANG CEO & Co-founder of WELT corp.

IR Session

- Medical Doctor degree at Yonsei University Medical Colleage (2009)
- Master of Public Health at Seoul National University (2014)
- Ph.D at Yonsei University School of Public Health (candidate)
- Public Health Doctor at Ministry of Health & Welfare (2009~2012)
- Creative Leader at SAMSUNG Electronics (2014~2016)
- CEO & Co-founder of WELT corp. (2016~)
- Adj. Professor of Yonsei university Medical school (2022~)

Kiwon Lee CEO / CTO @ Ybrain Inc.

IR Session

- Ybrain Inc. CEO/CTO (2014-Present)
- National Delegate of South Korea – ISO/IEC International Standard Joint Technology Committee for Brain Computer Interface (2022 – Present)
- Ybrain Inc. CTO (2012-2014)
- Samsung Electro-mechanics Inc. Senior Researcher (2012-2012)

Dongmin Kim JLK Inc. CEO & CTO

IR Session

- JLK Inc. CEO & CTO
- Graduate School of Engineering, The University of Tokyo, Japan Visiting Researcher
- Graduate School of Engineering, The University of Tokyo, Japan Researcher

KIM, il CEO of SurgicalMind, Inc.

IR Session

- CEO of SurgicalMind, Inc.(2017~ )
- CEO of ManiaMind. Co., Ltd.(2013~ )
- PD(Project Director) of T3 Ent.(2011~2013)
- PD(Project Director) of MGAME.(2002~2011)

Younghoon Cho MD Otolaryngologist Head of Medical, Asleep co.,ltd.

IR Session

- CEO, Clionic Lifecare Clinic
- Former Chief Strategy Officer and Head of US subsdiary of MedicalAI Inc
- Former Medical Director of Bodyfriend Co Ltd
- Graduated from Seoul National University College of Medicine
- Digital Transformation of Sleep Medicine by AI: Sleep Quality Measurement and
- Sleep Apnea Diagnosis Based on Breathing Sounds During Sleep

Eun Bo Shim CEO and Founder, AI Medic Inc

IR Session

- CEO and Founder, AI Medic Inc
- Director, National Research Laboratory funded by NRF of Korea
- Review Board, Engineering Division, National Research Foundation of Korea
- Professor, Mechanical and Biomedical Engineering, Kangwon National University
- Researcher, Harvard-MIT Health Science & Technology